A gene dosage‐dependent effect unveils NBS1 as both a haploinsufficient tumour suppressor and an essential gene for SHH‐medulloblastoma-Reference-Cited by-同舟云学术

A gene dosage‐dependent effect unveils NBS1 as both a haploinsufficient tumour suppressor and an essential gene for SHH‐medulloblastoma

Published:2022-08-10 Issue:6 Volume:48 Page:
ISSN:0305-1846
Container-title:Neuropathology and Applied Neurobiology
language:en
Short-container-title:Neuropathology Appl Neurobio

Author:

Petroni Marialaura¹²,Fabretti Francesca¹,Di Giulio Stefano¹,Nicolis di Robilant Vittoria¹,La Monica Veronica¹,Moretti Marta³,Belardinilli Francesca¹,Bufalieri Francesca¹,Coppa Anna³,Paci Paola⁴⁵,Corsi Alessandro¹,De Smaele Enrico³,Coni Sonia¹,Canettieri Gianluca¹²,Di Marcotullio Lucia¹,Wang Zhao‐Qi⁶,Giannini Giuseppe¹²

Affiliation:

1. Department of Molecular Medicine University La Sapienza Rome Italy

2. Istituto Pasteur‐Fondazione Cenci Bolognetti Rome Italy

3. Department of Experimental Medicine University La Sapienza Rome Italy

4. Department of Computer Engineering, Automation and Management University La Sapienza Rome Italy

5. Institute for Systems Analysis and Computer Science Antonio Ruberti National Research Council Rome Italy

6. Leibniz Institute on Aging‐Fritz Lipmann Institute (FLI) Jena Germany

Funder

Associazione Italiana per la Ricerca sul Cancro

German-Israeli Foundation for Scientific Research and Development

Leibniz-Gemeinschaft

Istituto Pasteur-Fondazione Cenci Bolognetti